262433-01-2

Basic information

• Product Name: Carbamic acid, (4-bromo-2-methoxyphenyl)-, 1,1-dimethylethyl ester (9CI)
• Synonyms: Carbamic acid, (4-bromo-2-methoxyphenyl)-, 1,1-dimethylethyl ester (9CI);tert-butyl (4-bromo-2-methoxyphenyl)carbamate
• CAS NO: 262433-01-2
• Molecular Formula: C₁₂H₁₆BrNO₃
• Molecular Weight: 302.16434
• Product Categories: N-BOC
• Mol File: 262433-01-2.mol
• Article Data: 8

Chemical Properties

• Boiling Point: 313.5°Cat760mmHg
• Flash Point: 143.4°C
• Appearance: /
• Density: 1.382g/cm³
• Vapor Pressure: 0.000496mmHg at 25°C
• Refractive Index: 1.558
• CAS DataBase Reference: Carbamic acid, (4-bromo-2-methoxyphenyl)-, 1,1-dimethylethyl ester (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, (4-bromo-2-methoxyphenyl)-, 1,1-dimethylethyl ester (9CI)(262433-01-2)
• EPA Substance Registry System: Carbamic acid, (4-bromo-2-methoxyphenyl)-, 1,1-dimethylethyl ester (9CI)(262433-01-2)

Safety Data

• Hazardous Substances Data: 262433-01-2(Hazardous Substances Data)

Usage

General Description

Carbamic acid, (4-bromo-2-methoxyphenyl)-, 1,1-dimethylethyl ester (9CI) is a chemical compound with the molecular formula C13H18BrNO3. It is an ester of carbamic acid and is typically used as an intermediate in the synthesis of pharmaceutical compounds and agrochemicals. Carbamic acid, (4-bromo-2-methoxyphenyl)-, 1,1-dimethylethyl ester (9CI) is a colorless to pale yellow liquid with a molecular weight of 303.192 g/mol. It is important to handle this chemical with caution as it may pose health risks if ingested, inhaled, or in contact with skin and eyes. Proper safety protocols should be observed when working with this compound, including the use of protective equipment and proper ventilation.

InChI:InChI=1/C12H16BrNO3/c1-12(2,3)17-11(15)14-9-6-5-8(13)7-10(9)16-4/h5-7H,1-4H3,(H,14,15)

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 59557-91-4 4-bromo-2-methoxyaniline 

Downstream Products

• 255873-36-0 tert-butyl-N-{4-[allyl(dimethyl)silyl]-2-methoxyphenyl}carbamate 
• 93-26-5 2-methoxyacetanilide 
• 5395-00-6 N-(2-methoxyphenyl)benzamide 
• 55860-22-5 2-chloro-N-(2-methoxyphenyl)acetamide 
• 7157-34-8 N-(2-methoxyphenyl)propionamide 
• 3245-90-7 N-<4-Chlor-butyryl>-2-methoxy-anilin 
• 262433-02-3 tert-Butyl N-[2-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-carbamate 
• 1124330-12-6 tert-butyl (2-methoxy-4-(piperidin-4-yl)phenyl)aminocarboxylate 

Relevant articles and documents

Tyrosine Kinase Inhibitor And Uses Thereof

Disclosed is a compound of Formula (I) or a pharmaceutically acceptable salt, ester, or solvate thereof, or their stereoisomers, which can be used as tyrosine kinase inhibitor. Also disclosed is a method for preparing the compound, a pharmaceutical composition and a kit comprising the compound, and uses of the compound. The compound can be used as tyrosine kinase inhibitor, or can be used to reduce or inhibit activity of EGFR or mutant thereof, such as EGFR mutant comprising T790M mutation, in a cell, or to treat and/or prevent a disease associated with overactivity of EGFR, such as cancer.

Thienopyridine kinase inhibitors

Compounds having the formula are useful for inhibiting protein tyrosine kinases. The present invention also discloses methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.

Thienopyridine and furopyridine kinase inhibitors

Compounds having the formula are useful for inhibiting protein tyrosine kinases. The present invention also discloses methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.